Evaluating Vivitrol, the newest anti-addiction drug—actually an injectable form of an old pill. It's definitely better than nothing. But is it $1,100 a month better?
Examining the medical, moral, and monetary decisions that Alkermes made to bring its drug Vivitrol to market—including a controversial trial in Russia. Are the critics right to cry foul?